Press Releases
-
World Gynecologic Oncology Awareness Day (World GO Day): On September 20, 2022, turn the globe purple!
ESGO has announced a new challenge for World Gynecologic Oncology Awareness Day, to inspire and motivate women all around the world to improve their health by incorporating regular physical activity into their daily routine.
Sep 7, 2022
-
Trinity Health Partners with Orexo US to Expand Patient Access to Digital Therapeutics
Sep 6, 2022
-
Cytel expansion unlocks innovative clinical development expertise for APAC biopharma sector
Cytel Inc. has expanded its operations into the Asia-Pacific region (APAC).
Sep 6, 2022
-
“Genome Editing of Immune Cells” - New Lonza Virtual Event
Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery.
Sep 6, 2022
-
mdgroup Chief Operating Officer LaQuinta Jernigan Honoured as one of 100 Most Inspiring People in Life Sciences 2022
mdgroup Chief Operating Officer LaQuinta Jernigan Honoured as one of 100 Most Inspiring People in Life Sciences 2022 Recognized for championing diversity and collaboration within the clinical trials industry
Sep 6, 2022
-
Takara Bio announces partnership for the distribution of CE-IVD solutions for respiratory tract infections
Takara Bio Europe announced today a partnership with the German company BioeXsen GmbH for the distribution of in vitro diagnostic solutions for the qPCR detection of common pathogens found in respiratory tract infections.
Sep 5, 2022
-
CapnoPharm awarded as drug delivery platform Capnodrug® reaches finals of Reuters Pharma Europe Award 2022
CapnoPharm is proud to announce its selection as Finalist of the prestigious Reuters Pharma Europe Award 2022 for its Cancer drug delivery innovation - Capnodrug® - in the Health Entrepreneur Award category.
Sep 5, 2022
-
Sakura Finetek offers the optimal advanced stained slide with the new Tissue-Tek Genie®
Sakura Finetek Europe has announced the launch of its newest solution Tissue-Tek Genie, an Advanced staining system.
Sep 4, 2022
-
Medix Biochemica Appoints Dr. Michele Pedrocchi, Former Head of Business Development for Roche Diagnostics, to its Board of Directors
Medix Biochemica has announced the appointment of Dr. Michele Pedrocchi to their Board of Directors.
Sep 4, 2022
-
Hydrophilic Polymers Exhibit Boundless Opportunities for Multiple Fields
Sep 2, 2022
-
Insights, Strategies, and Practical Suggestions on Pre-formulation Studies for Pharmaceuticals
Sep 2, 2022
-
Creative Peptides Released One-Stop Solution for All Peptide Drug Conjugate Needs
Aug 21, 2022
-
Creative Biogene Updates Gene Knockout Services for C-elegans Using Mos 1-Mediated Deletion Method
Aug 8, 2022
-
BOC Sciences Developed Strain Expression Systems to Enhance Fermentation Productivity
Aug 30, 2022
-
PseudoUridine Phosphoramidites for Efficient and Reliable Syntheses of RNA Oligonucleotides
Aug 16, 2022
-
Clinical trials legal service provider cements expansion plans with first US office
Clinical trials legal service provider cements expansion plans with first US office CTA Focus’ North Carolina base will provide seamless access to world-class services
Aug 31, 2022
-
Curebase Names Digital Infrastructure Veteran Matt Lanier as VP of Engineering
Curebase, a company committed to democratizing access to clinical studies, has named veteran digital infrastructure executive Matt Lanier as vice president of engineering.
Aug 29, 2022
-
Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future
Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future CluePoints Hosts RBQM Live 2022 as the Premier Event Sponsor
Aug 29, 2022
-
Rho Announces Findings from Study it Coordinated to Explore Therapy for Reducing Asthma Attacks Among Disadvantaged Urban Youth
Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced findings from a clinical trial it supported as the Statistical and Clinical Coordinating Center for the Inner-City Asthma Consortium (ICAC) to assess the efficacy of a monoclonal antibody for reducing asthma attacks in disadvantaged urban youth.
Aug 10, 2022
-
Indica Labs Announces Collaboration with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) for the Development of an AI-based Algorithm for the Automated Reporting of Lymph Node Status in Colon Cancer
Indica Labs and The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) has announced today an agreement to collaborate on the development of an AI-based digital pathology solution for the detection of cancer within lymph nodes from colorectal surgery cases.
Aug 29, 2022






